Adam D. Levy

ACRV

Adam D. Levy serves as officer: Chief Financial Officer at Acrivon Therapeutics, Inc. Common Stock (ACRV). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$30.0K

Total Sells

2 trades

$3.3K

Net Position

Net Buyer

$26.7K

Companies Traded

ACRV

Active Period

Aug 2025 – Aug 2026

4 total trades

Most Recent

Sell ACRV

Aug 6, 2026 · $1.8K

Adam D. Levy's Insider Trading at Acrivon Therapeutics, Inc. Common Stock (ACRV)

Buys

2 · $30.0K

Sells

2 · $3.3K

Total Shares Bought

17,664

Total Shares Sold

2,306

ACRV Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 6, 2026	Sell	1,142	$1.57	$1.8K	66,008
Jan 16, 2026	Buy	8,832	$1.70	$15.0K	20,983
Jan 14, 2026	Buy	8,832	$1.70	$15.0K	0
Aug 1, 2025	Sell	1,164	$1.26	$1.5K	0

Related Insiders

Peter Blume-Jensen

President and CEO

ACRVSell · Aug 27, 2026

Eric Devroe

officer: Chief Operating Officer

ACRVSell · Aug 20, 2026

Erick Gamelin

officer: Chief Development Officer

ACRVSell · Aug 20, 2026

Mary Miller

officer: Chief Legal Officer

ACRVSell · Aug 20, 2026

Katharine Peterson

officer: Chief Accounting Officer

ACRVSell · Aug 20, 2026

Explore More Insider Trading Data

ACRV Insider Trading Activity

View all insider trades at Acrivon Therapeutics, Inc. Common Stock

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity